By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Q-Med AB 

Seminariegatan 21

Uppsala    752 28  Sweden
Phone: 46-18-474-90-00 Fax: +46-18-474-90-01



Company News
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012 10:33:20 AM
Q-Med AB Agrees to Be Acquired by Galderma Pharma S.A. for $970 Million 12/15/2010 8:12:53 AM
Oceana Therapeutics and Q-Med AB Achieve Key Milestone With the Submission of a Premarketing Application for FDA Approval of Solesta(R) 4/12/2010 9:52:43 AM
Q-Med AB and Oceana Therapeutics Take Major Step Towards SOLESTA(TM) US Regulatory Filing 12/7/2009 11:56:05 AM
Q-Med AB: Invitation to Conference call Regarding Interim Report January-September, 2009 10/12/2009 11:11:52 AM
Q-Med AB Trading Update for the Third Quarter of 2009 9/18/2009 10:10:46 AM
Q-Med AB And Smith & Nephew plc (SNN) Takes Durolane(TM) PMA In USA To Next Stage 8/20/2009 8:34:39 AM
US Panel Rejects Q-Med AB, Smith & Nephew Inc. Knee Treatment 8/20/2009 6:47:05 AM
US FDA to Seek Panel's Advice on Q-Med AB's Studies 8/17/2009 7:25:38 AM
Q-Med AB Invites to Conference Call Regarding Half Year Report January-June, 2009 7/13/2009 9:49:35 AM